Skip to main navigation Skip to search Skip to main content

A new multiplex PCR strategy for the simultaneous determination of four genetic polymorphisms affecting HIV-1 disease progression

Thomas Birk Kristiansen, Troels Bygum Knudsen, Stine Dahl Ohlendorff, Jesper Eugen-Olsen

40 Citations (Scopus)

Abstract

The CCR5 Delta32, CCR2 64I, SDF1 3'A, and CCR5 promoter 59029 polymorphisms have been suggested to influence HIV-1 disease progression. Furthermore, the CCR5 Delta32 and the CCR2 64I polymorphisms have been associated with various other diseases. The purpose of the present study was to develop a multiplex assay for the simultaneous determination of these four polymorphisms. Results obtained with the multiplex assay were compared to results obtained by conventional RFLP-PCR and no differences were observed. The multiplex assay offers a quick tool for the determination of the CCR5 Delta32, CCR2 64I, SDF1 3'A, and CCR5 promoter 59029 A/G polymorphisms.
Original languageEnglish
JournalJournal of Immunological Methods
Volume252
Issue number1-2
Pages (from-to)147-51
Number of pages5
ISSN0022-1759
DOIs
Publication statusPublished - 2001

Keywords

  • Chemokine CXCL12
  • Chemokines, CXC
  • Disease Progression
  • HIV Infections
  • HIV-1
  • Humans
  • Polymerase Chain Reaction
  • Polymorphism, Genetic
  • Receptors, CCR2
  • Receptors, CCR5
  • Receptors, Chemokine

Fingerprint

Dive into the research topics of 'A new multiplex PCR strategy for the simultaneous determination of four genetic polymorphisms affecting HIV-1 disease progression'. Together they form a unique fingerprint.

Cite this